Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

Overview

About this study

The purpose of this study is to determine if EMTT is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Men and women with osteoarthritis of the foot and/or ankle confirmed via radiographs.

Exclusion Criteria:

  • Pacemaker, active cancer, shrapnel, metal in eye, implantable devices that are not compatible with MRIs, concurrent foot or ankle condition or injury, prior foot or ankle surgery for osteoarthritis, steroid, platelet rich plasma, or hyaluronic acid injection within 2 months of the treatment.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/26/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Bondi

Closed for enrollment

Contact information:

Ciara Terry

(507) 538-3562

Terry.Ciara@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597168

Mayo Clinic Footer